![2,3,13,14-Tetrabromo-6,7,9,10,17,18,20,21-octahydrodibenzo[B,K][1,4,7,10,13,16]hexaoxacyclooctadec…](https://static.cymitquimica.com/products/3D/img/QBA10011.png "Clique para ampliar")
2,3,13,14-Tetrabromo-6,7,9,10,17,18,20,21-octahydrodibenzo[B,K][1,4,7,10,13,16]hexaoxacyclooctadecine
CAS: 40100-11-6
Ref. 3D-QBA10011
| 5g | A consultar | ||
| 10g | A consultar |
Informação sobre produto
2,3,13,14-Tetrabromo-6,7,9,10,17,18,20,21-octahydrodibenzo[B,K][1,4,7,10]hexaxacyclooctadecine (TBX) is a boswellic acid derivative with potent anti-inflammatory activity. TBX inhibits the production of proinflammatory cytokines and nitric oxide in macrophages. It also has a protective effect against radiation-induced oxidative stress and inflammation in mice. TBX has been shown to decrease blood pressure in women with hypertension. In addition to its anti-inflammatory properties TBX also has antitumor activity and can inhibit the growth of human cancer cells by binding to DNA. It is also active against two types of human papilloma virus (HPV) that cause cervical cancer. This drug may be useful for the treatment of infants with developmental disorders such as autism spectrum disorder or attention deficit
Propriedades químicas
Consulta técnica sobre: 3D-QBA10011 2,3,13,14-Tetrabromo-6,7,9,10,17,18,20,21-octahydrodibenzo[B,K][1,4,7,10,13,16]hexaoxacyclooctadecine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
